COSMO Pharmaceuticals SA Total Liabilities

Latest as of December 2025: CHF123.36 Million CHF ≈ $155.96 Million USD

COSMO Pharmaceuticals SA total liabilities. Based on the latest financial reports, COSMO Pharmaceuticals SA (COPN) has total liabilities worth CHF123.36 Million CHF (≈ $155.96 Million USD) as of December 2025. Total liabilities represent everything the company owes to external parties, combining both current liabilities—like accounts payable, short-term debt, and accrued expenses—and non-current liabilities such as long-term debt, pension obligations, lease liabilities, and deferred tax liabilities. Check COPN financial resilience to evaluate the company's liquid asset resilience ratio.

Total Liabilities of COSMO Pharmaceuticals SA (2004–2025)

Total liabilities of COSMO Pharmaceuticals SA from 2004 to 2025. This chart illustrates how COSMO Pharmaceuticals SA's total liabilities have evolved over time, based on quarterly financial data. Explore COPN long-term investments to assets to see how much of total assets are deployed in long-term investments.

COSMO Pharmaceuticals SA Competitors by Total Liabilities

The table below lists competitors of COSMO Pharmaceuticals SA ranked by their total liabilities.

Company	Country	Total Liabilities
Shanghai Datun Energy Resources Co Ltd SHG:600508	China	CN¥9.06 Billion
Canfor Corporation TO:CFP	Canada	CA$2.43 Billion
Doosan Fuel Cell Co Ltd KO:336260	Korea	₩1.04 Trillion
Aygaz AS IS:AYGAZ	Turkey	TL12.66 Billion
Cairn Homes PLC IR:C5H	Ireland	€522.49 Million
Hangzhou DPtech Technologies Co Ltd SHE:300768	China	CN¥473.17 Million
REDOX Ltd AU:RDX	Australia	AU$187.94 Million
Rolls-Royce Holdings PLC LSE:RR	UK	GBX35.51 Billion

Liability Composition Analysis (2004–2025)

This chart breaks down COSMO Pharmaceuticals SA's total liabilities into key components over time: long-term debt, short-term debt, other current liabilities, and other non-current liabilities. Toggle between absolute values and percentage view to see how the composition has shifted. For the complete balance sheet picture, see COSMO Pharmaceuticals SA total assets.

Liquidity & Leverage Metrics

COSMO Pharmaceuticals SA Total Liabilities Ratios Explained

COSMO Pharmaceuticals SA total liabilities ratios compare its liabilities with its current assets, cash and shareholder equity.

Metric	Value	Description
Current Ratio	7.18	Measures ability to pay short-term obligations (Current Assets ÷ Current Liabilities)
Quick Ratio	N/A	More stringent measure of short-term liquidity ((Current Assets - Inventory) ÷ Current Liabilities)
Cash Ratio	N/A	Most conservative liquidity measure (Cash & Equivalents ÷ Current Liabilities)
Debt to Equity	0.26	Measures financial leverage (Total Liabilities ÷ Shareholder Equity)
Debt to Assets	0.20	Portion of assets financed with debt (Total Liabilities ÷ Total Assets)

Liability Trends Comparison

This chart compares key liability metrics across different time periods, showing how COSMO Pharmaceuticals SA's debt structure has evolved. The comparison includes total liabilities, long-term debt, and current liabilities.

Annual Total Liabilities for COSMO Pharmaceuticals SA (2004–2025)

The table below shows the annual total liabilities of COSMO Pharmaceuticals SA from 2004 to 2025.

Year	Total Liabilities	Change
2025-12-31	CHF123.36 Million ≈ $155.96 Million	-12.93%
2024-12-31	CHF141.68 Million ≈ $179.12 Million	+13.40%
2023-12-31	CHF124.94 Million ≈ $157.96 Million	-57.76%
2022-12-31	CHF295.80 Million ≈ $373.98 Million	+1.00%
2021-12-31	CHF292.88 Million ≈ $370.28 Million	+49.40%
2020-12-31	CHF196.04 Million ≈ $247.84 Million	+2.41%
2019-12-31	CHF191.43 Million ≈ $242.02 Million	+5.86%
2018-12-31	CHF180.83 Million ≈ $228.62 Million	+549.14%
2017-12-31	CHF27.86 Million ≈ $35.22 Million	-0.21%
2016-12-31	CHF27.92 Million ≈ $35.29 Million	-18.60%
2015-12-31	CHF34.30 Million ≈ $43.36 Million	-53.23%
2014-12-31	CHF73.33 Million ≈ $92.71 Million	+220.94%
2013-12-31	CHF22.85 Million ≈ $28.89 Million	-16.13%
2012-12-31	CHF27.24 Million ≈ $34.44 Million	+86.55%
2011-12-31	CHF14.60 Million ≈ $18.46 Million	-56.35%
2010-12-31	CHF33.46 Million ≈ $42.30 Million	+186.73%
2009-12-31	CHF11.67 Million ≈ $14.75 Million	-19.68%
2008-12-31	CHF14.53 Million ≈ $18.37 Million	+20.26%
2007-12-31	CHF12.08 Million ≈ $15.27 Million	-33.86%
2006-12-31	CHF18.27 Million ≈ $23.09 Million	-33.77%
2005-12-31	CHF27.58 Million ≈ $34.87 Million	+13.30%
2004-12-31	CHF24.34 Million ≈ $30.78 Million	--

About COSMO Pharmaceuticals SA

SW:COPN Switzerland Drug Manufacturers - General

Market Cap

$1.27 Billion

CHF1.01 Billion CHF

Market Cap Rank

#7622 Global

#112 in Switzerland

Share Price

CHF58.70

Change (1 day)

-2.17%

52-Week Range

CHF58.40 - CHF124.80

All Time High

CHF171.24